These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3238364

  • 1. Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease.
    Bartlett RR, Popovic S, Raiss RX.
    Scand J Rheumatol Suppl; 1988; 75():290-9. PubMed ID: 3238364
    [Abstract] [Full Text] [Related]

  • 2. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 3. A behavioral profile of autoimmune lupus-prone MRL mice.
    Sakić B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA.
    Brain Behav Immun; 1992 Sep 15; 6(3):265-85. PubMed ID: 1392101
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S.
    Clin Exp Immunol; 1995 Apr 15; 100(1):111-7. PubMed ID: 7697909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG, Tait B, Tonzetich J, Waterfield JD.
    J Autoimmun; 1994 Oct 15; 7(5):561-73. PubMed ID: 7530961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 13. Effect of several kinds of drugs on the development of autoimmunity in MRL/Mp-lpr/lpr mice; lack of correlation between the suppression of autoantibody production and prevention of autoimmune disease.
    Mihara M, Ohsugi Y.
    J Pharmacobiodyn; 1989 Feb 15; 12(2):100-6. PubMed ID: 2526211
    [Abstract] [Full Text] [Related]

  • 14. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC, Misu N, Furukawa H, Watanabe Y, Terada M, Komori H, Miyazaki T, Nose M, Ono M.
    Ann Rheum Dis; 2006 Apr 15; 65(4):495-500. PubMed ID: 16150787
    [Abstract] [Full Text] [Related]

  • 15. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar 15; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
    Popovic S, Bartlett RR.
    Agents Actions; 1987 Aug 15; 21(3-4):284-6. PubMed ID: 3687582
    [Abstract] [Full Text] [Related]

  • 18. 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
    Schorlemmer HU, Bartlett RR, Seiler FR.
    Agents Actions; 1991 Sep 15; 34(1-2):151-5. PubMed ID: 1793021
    [Abstract] [Full Text] [Related]

  • 19. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
    Prud'Homme GJ, Park CL, Fieser TM, Kofler R, Dixon FJ, Theofilopoulos AN.
    J Exp Med; 1983 Feb 01; 157(2):730-42. PubMed ID: 6600490
    [Abstract] [Full Text] [Related]

  • 20. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.